New Dual-Target Drug May Help Overcome Immunotherapy Resistance in Pancreatic Cancer | Newswise
Unsure
A team of researchers from the College of Pharmacy and Rogel Cancer Center at the University of Michigan has developed a new strategy to improve immunotherapy treatments for pancreatic cancer.
The Verdict
ClassificationUnsure
ConfidenceMedium confidence
Analyzedtext, image
ImageAI Generated
Community Verdict
Sign in to vote
Be the first to vote on this assessment.
Embed Badge
Add this badge to your site to show the AI classification for this content.
[](https://real.press/content/fe56ad55-8b0f-42f4-be42-24af983dddd7)